TREM2 and Alzheimer disease: Heterozygous loss-of-function variants in TREM2 were associated with the increasing AD risk (Guerreiro et al., 2013), and another study presented that they also increased the risk of the other neurodegenerative diseases, such as FTD, PD, and ALS (Carmona et al., 2018).